This page contains a Flash digital edition of a book.
funding focus.


The funding landscape for


regenerative medicine in the UK By Zahid Latif, Head of Healthcare, Technology Strategy Board


Zahid Latif


Since 2008, the Technology Strategy Board has been working with its partners to develop a programme to support innovative UK businesses working in the regenerative medicines areas. The culmination of this work has been the delivering the ‘Regen Med Programme’ with investment of over £22m working with a partnership including the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, and the Scottish Government.


The support so far has gone to over 62 business led projects with the final tranche of projects due to be funded and announced in the autumn of 2011


The support so far has gone to over 62 business led projects with the final tranche of projects due to be funded and announced in the autumn of 2011. The projects cover the breadth of regenerative medicine therapies and underpinning technologies to support the development of manufacturing, safety, efficacy testing and business models.


Looking forward the Technology Strategy Board is looking to establish a technology and Innovation centre to support the companies in the commercial development of cell therapies and is currently in the process of identifying the leadership team who will be responsible for establishing the centre in April 2012.


We have also been working with our research council partners, the Department of Business, Innovation and Skills and the community to take stock of the regenerative medicine sector and plan our forward strategy for investments, co-ordinating across the multiple funders of regenerative medicine.


Zahid Latif, Head of Healthcare, explains: “Building consortia and bringing the community together is a key component of the Technology Strategy Board’s Regen Med programme. We really value the support that Regener8 has given us and the Healthtech and Medicines KTN in reaching out to the academic, business and clinical communities to help us address the challenges in developing regenerative medicines.”


18 www.regener8.ac.uk


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36